CLYM
Climb Bio Inc
10.90$
+1.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -23.7% | +3.4% | +26.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -16.2% | +43.2% | +126.6% | +5.6% | +24.3% | +3.4% | +14.9% | +20.1% | +6.2% | -51.4% | +15.7% | +16.1% | -35.5% | -22.0% | +8.7% | -65.1% | +4,730.9% | -88.2% | -4.5% | +190.8% | -62.1% | +38.0% | +51.4% | -32.0% | +4.1% | – | |
| – | -24.4% | +25.8% | +392.6% | +44.3% | +31.4% | +16.5% | +12.7% | +27.4% | +1.2% | -9.0% | +3.1% | +282.9% | -82.9% | -29.8% | -6.1% | -4.1% | +91.6% | +49.8% | -9.8% | +14.9% | -27.9% | +41.9% | -4.5% | +5.0% | -3.3% | – | |
| – | -17.6% | +40.5% | +568.7% | -54.5% | +26.6% | +7.8% | +14.1% | +22.7% | +4.3% | -36.2% | +9.2% | +145.3% | -71.4% | -25.5% | +2.4% | -41.3% | +1,775.9% | -79.2% | -7.0% | +111.0% | -53.8% | +40.0% | +29.4% | -21.2% | +1.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.